Metraipolis › archive › dc_99dac3250feb

ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma — Europe PMC PMID:40830586

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40830586
DOI
10.1038/s41598-[numero omesso]-6
License (as archived)
solo-consultazione
Archived
2026-11-10T12:27:11.217Z
SHA-256 of the archived text
59b8993ccd04de912f1fb9b4f64e7d0a85f7c786566e759a9c566835c275506b
Stable URL of this page
https://metraipolis.com/documento/dc_99dac3250feb

How to cite

ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma — Europe PMC PMID:40830586 — Europe PMC (en), https://europepmc.org/article/MED/40830586 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_99dac3250feb (Metraipolis archive dc_99dac3250feb, sha256 59b8993ccd04de912f1fb9b4f64e7d0a85f7c786566e759a9c566835c275506b)
BibTeX
@misc{dc99dac3250feb,
  title = {ZEB1 stratifies the response to Sorafenib and Mdivi-1 combination therapy in hepatocellular carcinoma — Europe PMC PMID:40830586},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40830586},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_99dac3250feb; sha256 59b8993ccd04de912f1fb9b4f64e7d0a85f7c786566e759a9c566835c275506b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830586. Agents can read the archived copy with the MCP tool read_document.